Mouse models of schizophrenia
This week we take a look at two articles form early 2006
focused on animal models of schizophrenia. Each of the articles develops and
tests a distinct mouse model for schizophrenia. Importantly, both of these
models are especially focused on the cognitive symptoms of schizophrenia, which
other models do not present and which are not primarily targeted by current
treatment in humans.
In the article by Moore and colleagues (2006), the model
is achieved by disrupting embryonic development of paralimbic frontal and
temporal cortices, while in the article by Kellendonk and colleagues (2006) the
model is achieved by overexpressing D2 receptors in the striatum. Results in cognitive
tasks are not unlike in the two models, which highlights the fact the
schizophrenia might be better conceptualized as a heterogeneous disease in
which different neurobiological substrates given origin to similar symptoms
across individuals. This means that not one model might be truer to the human
disorder than the other, but they might better reflect the nature of the disorder
to different degrees in different individuals. Another important result from
both studies were the findings that there is a critical period during embryonic
development during which dysfunction can result in schizophrenic like symptoms.
Here, the two articles agree very closely on the time-frame for this dysfunction
in mice – the Moore et. al (2006) found that MAM should disrupt development at
week 17 and Kellendonk et. al (2006) found that the overexpression of D2 receptors
in the striatum of transgenic occurs during week 17 as well. While this
highlights the relevance of neurodevelopmental disruption in schizophrenia,
these models fail to account for why the disorder appears in some individuals
and not other. This is common across many animal models, where a targeted
disruption result sin deficit in all individuals, which rarely is the case in
humans, where identical twins might not both develop a disorder due to environmental
factors.
In conclusion, here two animal models for some symptoms of
schizophrenia are presented. While they might not be ideal to inform on the
disease as a whole, they can very well inform about different neural substrates
that are likely be behind some of the symptoms of schizophrenia observed in
humans.
Comments
Post a Comment